Azalea Therapeutics

Redefining precision genomic medicines, in vivo

Berkeley, United States · Founded 2023 · $82.0M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$82.0M
Last Round
$65.0M Series ANov 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Azalea Therapeutics is a Berkeley-based biotechnology company redefining precision genomic medicines in vivo, spun out of Jennifer Doudna's UC Berkeley lab. The company is pioneering proprietary Enveloped Delivery Vehicles (EDVs) that selectively locate T cells inside the body and deliver genome-editing cargo to a precise genomic locus, turning a patient's own T cells into cancer immunotherapies without removing cells for lab manipulation. Azalea launched in November 2025 with $82 million in financing.

Summary

Azalea Therapeutics is a Biotech company based in Berkeley, United States, founded in 2023. It has raised $82.0M in total across 2 rounds, most recently a $65.0M Series A round in Nov 2025. Investors include Third Rock Ventures, RA Capital Management and Sozo Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ANov 2025
$65.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Azalea Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/azalea-therapeutics"><img src="https://indexed.vc/api/badge/company/azalea-therapeutics" alt="Azalea Therapeutics on Indexed.vc" width="260" height="76" /></a>